File HF743 ("Bans step therapy delays for insulin drugs") is before the Minnesota Legislature and has not been decided. Latest step (March 12, 2026): Author added.
Minnesota file HF743, before the Minnesota Legislature. Still to be decided as of 2026-03-12.
Insulin users bypass insurance approval wait times Patients prescribed insulin no longer wait for insurers to require cheaper drugs first; they access their doctor's choice immediately.
Insurance companies lose cost-control tool for diabetes Insurers can no longer use step therapy to steer patients toward lower-cost alternatives, potentially raising overall insulin spending.
May increase premiums or out-of-pocket costs Removing step-therapy barriers could raise insulin costs for insurers, who may pass increases to all plan members or raise deductibles.
Use of step therapy protocol prohibited for insulin drugs.
Read the official record for HF743
See everything up for a vote · This week in Minnesota · See what we have filed with the clerk